Methodologies to assess brain drug delivery in lead optimization

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Neuroscience

Background:

• Lead optimization for CNS-active drugs requires accurate measurement of free drug exposure in the central nervous system (CNS).
• Current experimental methodologies are insufficient for generating pharmacologically relevant data on CNS drug exposure.
• This deficiency may contribute to the lack of successful CNS drug discovery strategies.

Purpose of the Study:

• To evaluate existing methods for estimating drug delivery to the brain.
• To discuss the relevance of these methods concerning CNS free drug exposure.
• To propose a shift in focus towards the extent of drug delivery as a key parameter.

Main Methods:

• Literature review and evaluation of experimental methodologies for brain drug delivery assessment.
• Analysis of the pharmacological relevance of measured parameters (e.g., permeability vs. extent of delivery).
• Discussion of the implications for CNS drug discovery strategies.

Main Results:

• The extent of drug delivery is a more critical parameter than permeability for CNS drug effects.
• Permeability can vary widely while still allowing therapeutic CNS effects.
• Current approaches may lead to the development of overly lipophilic compounds.

Conclusions:

• There is an urgent need for comprehensive data on brain drug delivery, transporter affinities, and in vivo behavior.
• Future predictive models (in vitro and in silico) should prioritize active transport asymmetry across the blood-brain barrier (BBB) over simple permeability.
• This paradigm shift could facilitate the development of more effective CNS-active drugs.